tiprankstipranks
Trending News
More News >
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market

Alembic Pharmaceuticals Limited (APLLTD) Ratios

Compare
1 Followers

Alembic Pharmaceuticals Limited Ratios

IN:APLLTD's free cash flow for Q4 2025 was ₹0.70. For the 2025 fiscal year, IN:APLLTD's free cash flow was decreased by ₹ and operating cash flow was ₹0.11. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.12 2.12 1.78 1.67 2.01
Quick Ratio
0.99 0.99 0.88 0.73 0.85
Cash Ratio
0.08 0.08 0.05 0.04 0.08
Solvency Ratio
0.55 0.55 0.34 0.43 0.81
Operating Cash Flow Ratio
0.55 0.55 0.44 0.32 1.14
Short-Term Operating Cash Flow Coverage
1.87 1.87 1.14 0.88 4.88
Net Current Asset Value
₹ -1.02B₹ 14.51B₹ 10.98B₹ 9.76B₹ 9.36B
Leverage Ratios
Debt-to-Assets Ratio
0.08 0.08 0.12 0.10 0.09
Debt-to-Equity Ratio
0.11 0.11 0.17 0.14 0.11
Debt-to-Capital Ratio
0.10 0.10 0.14 0.12 0.10
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.04
Financial Leverage Ratio
1.34 1.34 1.41 1.36 1.31
Debt Service Coverage Ratio
1.94 1.94 1.02 1.27 4.16
Interest Coverage Ratio
10.25 10.25 8.73 33.13 80.95
Debt to Market Cap
0.02 0.02 0.07 0.04 0.03
Interest Debt Per Share
28.97 28.97 39.28 37.38 30.95
Net Debt to EBITDA
1.05 0.41 0.91 0.71 0.31
Profitability Margins
Gross Profit Margin
36.43%36.43%69.77%67.06%71.17%
EBIT Margin
11.05%11.05%7.16%12.29%26.23%
EBITDA Margin
15.44%15.44%12.58%17.67%29.71%
Operating Profit Margin
9.24%9.24%7.74%11.23%24.58%
Pretax Profit Margin
10.14%10.14%6.27%11.85%25.93%
Net Profit Margin
9.89%9.89%6.05%9.96%21.73%
Continuous Operations Profit Margin
9.89%9.89%6.60%9.96%21.73%
Net Income Per EBT
97.47%97.47%96.45%84.01%83.80%
EBT Per EBIT
109.73%109.73%81.00%105.56%105.49%
Return on Assets (ROA)
12.23%9.55%5.53%7.31%17.09%
Return on Equity (ROE)
21.49%12.78%7.83%9.95%22.36%
Return on Capital Employed (ROCE)
22.55%11.54%9.63%10.87%23.89%
Return on Invested Capital (ROIC)
14.97%10.32%8.12%8.07%18.41%
Return on Tangible Assets
12.96%9.55%5.53%7.48%17.95%
Earnings Yield
5.72%3.11%3.51%3.57%6.13%
Efficiency Ratios
Receivables Turnover
6.08 6.08 5.40 6.48 15.14
Payables Turnover
5.38 5.38 2.51 2.44 2.27
Inventory Turnover
2.41 2.41 1.16 1.07 1.02
Fixed Asset Turnover
2.03 2.03 1.88 1.33 1.45
Asset Turnover
0.97 0.97 0.91 0.73 0.79
Working Capital Turnover Ratio
4.30 4.30 4.68 4.29 5.25
Cash Conversion Cycle
145.65 143.74 237.48 247.65 220.23
Days of Sales Outstanding
46.88 60.06 67.57 56.31 24.11
Days of Inventory Outstanding
295.84 151.50 315.11 340.96 356.57
Days of Payables Outstanding
197.07 67.81 145.21 149.63 160.46
Operating Cycle
342.72 211.55 382.68 397.27 380.69
Cash Flow Ratios
Operating Cash Flow Per Share
40.86 40.86 36.83 28.10 75.53
Free Cash Flow Per Share
24.20 24.20 14.27 6.45 41.49
CapEx Per Share
16.66 16.66 22.56 21.65 34.04
Free Cash Flow to Operating Cash Flow
0.59 0.59 0.39 0.23 0.55
Dividend Paid and CapEx Coverage Ratio
1.66 1.66 1.13 0.79 2.22
Capital Expenditure Coverage Ratio
2.45 2.45 1.63 1.30 2.22
Operating Cash Flow Coverage Ratio
1.57 1.57 1.00 0.77 2.51
Operating Cash Flow to Sales Ratio
0.13 0.13 0.13 0.11 0.28
Free Cash Flow Yield
0.47%2.40%2.88%0.87%4.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
32.20 32.20 28.53 27.98 16.31
Price-to-Sales (P/S) Ratio
3.18 3.18 1.73 2.79 3.54
Price-to-Book (P/B) Ratio
4.12 4.12 2.23 2.78 3.65
Price-to-Free Cash Flow (P/FCF) Ratio
41.69 41.69 34.78 115.04 23.26
Price-to-Operating Cash Flow Ratio
24.69 24.69 13.48 26.39 12.78
Price-to-Earnings Growth (PEG) Ratio
0.40 0.40 -0.83 -0.51 0.47
Price-to-Fair Value
4.12 4.12 2.23 2.78 3.65
Enterprise Value Multiple
21.03 21.03 14.63 16.48 12.24
Enterprise Value
111.44B 202.25B 104.03B 152.33B 191.81B
EV to EBITDA
12.62 21.03 14.63 16.48 12.24
EV to Sales
2.93 3.25 1.84 2.91 3.64
EV to Free Cash Flow
234.17 42.51 37.08 120.22 23.86
EV to Operating Cash Flow
13.72 25.18 14.37 27.58 13.11
Tangible Book Value Per Share
245.13 245.13 222.34 258.58 244.86
Shareholders’ Equity Per Share
245.13 245.13 222.34 266.46 264.66
Tax and Other Ratios
Effective Tax Rate
0.03 0.03 0.04 0.17 0.19
Revenue Per Share
316.88 316.88 287.57 266.16 272.33
Net Income Per Share
31.33 31.33 17.40 26.50 59.18
Tax Burden
0.78 0.97 0.96 0.84 0.84
Interest Burden
0.98 0.92 0.88 0.96 0.99
Research & Development to Revenue
<0.01 0.07 <0.01 <0.01 <0.01
SG&A to Revenue
0.04 0.04 0.04 0.04 0.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.08 1.30 2.04 0.89 1.07
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis